First Interstate Bank purchased a new position in shares of CME Group Inc. (NASDAQ:CME – Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 944 shares of the financial services provider’s stock, valued at approximately $208,000.
Several other institutional investors and hedge funds have also recently bought and sold shares of CME. Capital International Investors boosted its stake in CME Group by 24.1% during the 1st quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock worth $3,403,557,000 after purchasing an additional 3,069,806 shares during the period. Ameriprise Financial Inc. raised its stake in CME Group by 11.3% in the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock valued at $1,038,676,000 after purchasing an additional 537,758 shares during the last quarter. GUARDCAP ASSET MANAGEMENT Ltd boosted its holdings in shares of CME Group by 1.1% during the first quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 4,009,068 shares of the financial services provider’s stock worth $863,112,000 after purchasing an additional 43,293 shares during the last quarter. Raymond James & Associates grew its holdings in CME Group by 3.2% in the second quarter. Raymond James & Associates now owns 3,029,145 shares of the financial services provider’s stock valued at $595,530,000 after purchasing an additional 94,302 shares during the period. Finally, Legal & General Group Plc increased its stake in CME Group by 6.6% during the second quarter. Legal & General Group Plc now owns 2,835,075 shares of the financial services provider’s stock worth $557,371,000 after acquiring an additional 176,004 shares during the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of brokerages have recently issued reports on CME. Deutsche Bank Aktiengesellschaft lifted their target price on CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research report on Thursday, August 15th. Oppenheimer raised their target price on shares of CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a research note on Thursday, October 24th. TD Cowen assumed coverage on shares of CME Group in a report on Thursday, September 26th. They set a “hold” rating and a $221.00 target price for the company. Redburn Atlantic downgraded shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 target price on the stock. in a research note on Tuesday, October 8th. Finally, Bank of America lifted their price objective on CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research report on Thursday, October 3rd. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $222.73.
Insiders Place Their Bets
In related news, Director Timothy S. Bitsberger sold 1,000 shares of the stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $226.96, for a total value of $226,960.00. Following the transaction, the director now directly owns 10,589 shares in the company, valued at $2,403,279.44. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, insider Timothy Francis Mccourt sold 1,374 shares of CME Group stock in a transaction that occurred on Monday, October 28th. The shares were sold at an average price of $227.12, for a total value of $312,062.88. Following the sale, the insider now owns 7,275 shares of the company’s stock, valued at approximately $1,652,298. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Timothy S. Bitsberger sold 1,000 shares of the company’s stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $226.96, for a total value of $226,960.00. Following the transaction, the director now directly owns 10,589 shares in the company, valued at $2,403,279.44. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 15,221 shares of company stock worth $3,351,895. 0.30% of the stock is currently owned by company insiders.
CME Group Trading Down 0.8 %
Shares of CME opened at $223.61 on Friday. The business’s fifty day moving average is $220.69 and its 200-day moving average is $209.48. CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $230.36. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. The firm has a market cap of $80.52 billion, a price-to-earnings ratio of 23.51, a PEG ratio of 5.72 and a beta of 0.55.
CME Group (NASDAQ:CME – Get Free Report) last posted its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.65 by $0.03. The firm had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business’s quarterly revenue was up 18.4% on a year-over-year basis. During the same period last year, the company earned $2.25 earnings per share. Equities analysts anticipate that CME Group Inc. will post 10.23 EPS for the current fiscal year.
CME Group Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were issued a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.06%. The ex-dividend date of this dividend was Monday, September 9th. CME Group’s payout ratio is 48.37%.
CME Group Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Articles
- Five stocks we like better than CME Group
- Learn Technical Analysis Skills to Master the Stock Market
- Battle of the Retailers: Who Comes Out on Top?
- What is the Hang Seng index?
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- MarketBeat Week in Review – 10/28 – 11/1
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.